Cellectis SA (CLLS)
1.85
-0.01
(-0.54%)
USD |
NASDAQ |
Nov 22, 12:13
Cellectis Max Drawdown (5Y): 97.08% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 97.08% |
| September 30, 2024 | 97.08% |
| August 31, 2024 | 97.08% |
| July 31, 2024 | 97.08% |
| June 30, 2024 | 97.08% |
| May 31, 2024 | 97.08% |
| April 30, 2024 | 97.08% |
| March 31, 2024 | 97.08% |
| February 29, 2024 | 97.08% |
| January 31, 2024 | 97.08% |
| December 31, 2023 | 97.08% |
| November 30, 2023 | 97.08% |
| October 31, 2023 | 97.08% |
| September 30, 2023 | 95.25% |
| August 31, 2023 | 95.25% |
| July 31, 2023 | 95.25% |
| June 30, 2023 | 95.25% |
| May 31, 2023 | 95.25% |
| April 30, 2023 | 95.25% |
| March 31, 2023 | 95.25% |
| February 28, 2023 | 95.20% |
| January 31, 2023 | 95.20% |
| December 31, 2022 | 95.20% |
| November 30, 2022 | 94.63% |
| October 31, 2022 | 94.06% |
| Date | Value |
|---|---|
| September 30, 2022 | 94.06% |
| August 31, 2022 | 93.80% |
| July 31, 2022 | 93.80% |
| June 30, 2022 | 93.80% |
| May 31, 2022 | 92.47% |
| April 30, 2022 | 91.05% |
| March 31, 2022 | 91.05% |
| February 28, 2022 | 88.87% |
| January 31, 2022 | 84.43% |
| December 31, 2021 | 83.61% |
| November 30, 2021 | 83.61% |
| October 31, 2021 | 83.61% |
| September 30, 2021 | 83.61% |
| August 31, 2021 | 83.61% |
| July 31, 2021 | 83.61% |
| June 30, 2021 | 83.61% |
| May 31, 2021 | 83.61% |
| April 30, 2021 | 83.61% |
| March 31, 2021 | 83.61% |
| February 28, 2021 | 83.61% |
| January 31, 2021 | 83.61% |
| December 31, 2020 | 83.61% |
| November 30, 2020 | 83.61% |
| October 31, 2020 | 83.61% |
| September 30, 2020 | 83.61% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
79.58%
Minimum
Nov 2019
97.08%
Maximum
Oct 2023
89.74%
Average
91.76%
Median
Max Drawdown (5Y) Benchmarks
| Edap TMS SA | 80.70% |
| DBV Technologies SA | 97.67% |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | 96.57% |
| Akari Therapeutics PLC | 98.63% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -73.91 |
| Beta (5Y) | 3.097 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 95.67% |
| Historical Sharpe Ratio (5Y) | -0.3547 |
| Historical Sortino (5Y) | -0.9011 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.61% |